A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), ...
SAN DIEGO — Patients with idiopathic pulmonary fibrosis (IPF) had significant improvements in lung function and reversal of lung fibrosis measures after 12 weeks of therapy with an investigational ...
Effect of plasma SPARC on outcome in cancer models. Background: The hedgehog (Hh) pathway plays a crucial role in the growth and patterning during embryonic development. We have shown that Hh pathway ...
Levodopa, or L-dopa, is considered the most effective treatment for Parkinson's disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, ...
Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul ...
A non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer, researchers from The University of Texas MD ...
NEW YORK, September 22, 2021 – Levodopa, or L-dopa, is considered the most effective treatment for Parkinson’s disease today. After a few years of treatment, however, almost all patients develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback